ClinicalTrials.Veeva

Menu

Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement

I

I.M. Sechenov First Moscow State Medical University

Status

Enrolling

Conditions

Thromboembolism
Anticoagulant-induced Bleeding

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of the study is to evaluate the frequency of cardiovascular and thromboembolic complications in patients with cardiovascular disease after lower limb joint replacement, the influence of known risk factors and strategies for perioperative prevention of thromboembolic complications on the frequency of cardiovascular complications and to develop approaches to optimize antithrombotic prevention tactics.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Informed consent
  • Age older than 18 y.o.
  • Cardiovascular disease
  • Indications for planned lower limb joint replacement surgery

Exclusion criteria

  • Pregnancy
  • Psychiatric disorders
  • Decompensated heart failure or acute heart failure
  • Known diagnosis of cancer

Trial design

1,000 participants in 3 patient groups

Low thromboembolic risk
Moderate thromboembolic risk
High thromboembolic risk
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Elena Okisheva, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems